Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Stem cell differentiation is crucial for skin barrier maintenance and its disruption can lead to skin diseases.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Minoxidil in breast milk may harm nursing infants.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Better awareness of chemotherapy's side effects improves self-care.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

People undergoing chemotherapy need better support and information to cope with hair loss.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Older adults have a wide range of skin conditions, with dry skin being very common and many also experiencing skin growths, itching, and infections.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.